C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives $9.86 Average PT from Brokerages
Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) have received an average recommendation of “Hold” from the seven research firms that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company. […]